All times listed are Pacific Standard Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.
- Home
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT(0380–0422) RA – Diagnosis, Manifestations, and Outcomes Poster ILocation: Poster Hall
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT(0423–0459) RA – Treatment Poster ILocation: Poster Hall
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0380: Use of Digital Health Tools to Evaluate Change in Clinical and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis Initiating Treatment with a JAKi or TNFiLocation: Poster Hall
Abstract Poster Presenter: – Global Healthy Living Foundation
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0381: Disease Burden, Patient Experiences, and Unmet Needs in Refractory Rheumatoid Arthritis: Insights from 20 Years of Real-World DataLocation: Poster Hall
Abstract Poster Presenter: – FORWARD, The National Databank for Rheumatic Diseases
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0382: Heterogeneity Within a “difficult to Treat” Rheumatoid Arthritis Patients Cohort: 36% May Have a More Benign Course and Have Distinct Characteristics at bDMARD or tsDMARD InitiationLocation: Poster Hall
Abstract Poster Presenter: – Rheumatology, Clinical Immunology and Allergy Department, Medical School, University of Crete, Greece; Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (FORTH)
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0383: Identification of Contributing Factors to Difficult-to-Treat Rheumatoid Arthritis (D2T RA) in a Cohort of 972 Patients Using a Natural Language Processing (NLP) ApproachLocation: Poster Hall
Abstract Poster Presenter: – Hautepierre Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0384: Targeting NET Formation in Early RA Patients; A Spin-off Study from the NORD-STARLocation: Poster Hall
Abstract Poster Presenter: – Amsterdam University Medical Centers & Reade Amsterdam
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0385: Heterogeneity of the Joint Location Supports the Importance of Local Factors in Early RA Synovitis : Analysis of the ERA UCLouvain Brussels CohortLocation: Poster Hall
Abstract Poster Presenter: – UCLouvain
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0387: The Association Between Inflammation, High-Sensitivity Cardiac Troponin T, and Cardiovascular Events in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0388: Left Ventricular Geometry Abnormalities Are Related to Higher Clinical Activity in Rheumatoid Arthritis PatientsLocation: Poster Hall
Abstract Poster Presenter: – Rheumatology Service Hospital Universitario "Dr. José E. González"
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0389: The Role of anti-CCP3 Antibodies in anti-CCP2 Antibody Negative Patients with Musculoskeletal SymptomsLocation: Poster Hall
Abstract Poster Presenter: – Polytechnic University of Marche
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0390: Statins Influence the Relationship Between ATP-binding Cassette Transporter A1 (ABCA1)-mediated Cholesterol Efflux and Coronary Atherosclerosis in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0391: Biologic Use Regulates the Impact of Inflammation on Ischemic Cardiovascular Risk in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0392: Novel Diagnostic Markers for Rheumatoid Arthritis Including Anti-CarP (Carbamylated Protein), Anti-Sa (Citrullinated Vimentin) and Anti-CEP1 (Citrullinated Enolase Peptide1) Are Frequently Positive in Diagnostic ProfilesLocation: Poster Hall
Abstract Poster Presenter: – LabCorp
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0393: Pulmonary Involvement in Patients with Seropositive and ACPA Positive Rheumatoid Arthritis (RA-ILD) – Novel Screening Protocol for Early Detection of Pulmonary InvolvementLocation: Poster Hall
Abstract Poster Presenter: – Kantonsspital St. Gallen
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0394: Higher Intakes of Red Meat Are Associated with an Increased Risk of Developing Seropositive but Not Seronegative Rheumatoid Arthritis - Results from a Nested Case-Control StudyLocation: Poster Hall
Abstract Poster Presenter: – Region Skåne
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0395: Prevalence of Objectively Measured Sleep Disturbance in Rheumatoid Arthritis (RA)Location: Poster Hall
Abstract Poster Presenter: – UCSF
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0396: Hydroxychloroquine Is Associated with a Decreased Risk of Non-alcoholic Fatty Liver Disease in Patients with Rheumatoid Arthritis: A Population-based, Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Taichung Veterans General Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0397: Obesity Is Associated with Worse Flare Symptoms and Quality of Life in Early Rheumatoid Arthritis: Insights from the RA Flare QuestionnaireLocation: Poster Hall
Abstract Poster Presenter: – Hospital for Special Surgery
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0398: Identification of Disease Activity-related miRNAs Through Artificial Neural Network Analysis in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – SUNY Downstate Health Sciences University New York
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0399: Differential Synovial Tissue Enrichment of Oxylipins and Their Mediators Across Rheumatoid Arthritis TrajectoryLocation: Poster Hall
Abstract Poster Presenter: – Division of Clinical Immunology – Fondazione Policlinico Universitario A. Gemelli IRCCS
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0400: Thresholds of Presenteeism Measurement Instruments for Unacceptable Work Participation and Future Adverse Work Outcomes in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Leiden University Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0401: Resolution of Swollen Joint Count Is an Important Clinical Objective in Early Rheumatoid Arthritis : Analysis of the UCLouvain Brussels ERA Cohort and Comparison with the Remission Composite IndexLocation: Poster Hall
Abstract Poster Presenter: – UCLouvain University / Sapienza University of Rome
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0402: Automated Detection and Quantification of Hand Joint Swelling in Rheumatoid Arthritis: Computer Vision, Deep Neural Network Models, and a Potential Biomarker for Disease Activity MonitoringLocation: Poster Hall
Abstract Poster Presenter: – CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0403: Disease Activity Is Associated with Frailty in Veterans with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Nebraska
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0404: Persistent Pain and Its Predictors After Start of Anti-TNF Therapy in Rheumatoid Arthritis – Is Line of Treatment Linked to Different Pain Patterns?Location: Poster Hall
Abstract Poster Presenter: – Lund University and Skane University Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0405: Clinical Features of Anti-Th/To Antibodies-positive Systemic Sclerosis Patients: A Single-center Retrospective StudyLocation: Poster Hall
Abstract Poster Presenter: – kanazawa university
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0406: Obesity Is a Risk Factor for Poor Response to Treatment in Early Rheumatoid Arthritis – a NORD-STAR Spin-Off StudyLocation: Poster Hall
Abstract Poster Presenter: – University of Gothenburg
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0407: Meteorological Conditions Contribute to the Joint Ultrasound Findings in Patients with Rheumatoid Arthritis: Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Nagasaki University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0408: The Role of Synovial Biopsy in Evaluating Rheumatoid Arthritis Acitivity in Patients: Findings from a Study of 30 Patients Treated with AdalimumabLocation: Poster Hall
Abstract Poster Presenter: – The first affiliated hospital of Nanchang university
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0409: Prevalence of Pulmonary Manifestations in Patients with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, and Peripheral SpondyloarthritisLocation: Poster Hall
Abstract Poster Presenter: – University Hospital Bonn
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0410: Usefulness of RAPID3 in Assessing Unmet Needs of Patients with Rheumatoid Arthritis in Remission or with Low Disease Activity -a Multicenter Observational Study: T-FLAG Study-Location: Poster Hall
Abstract Poster Presenter: – Nagoya University Graduate School of Medicine
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0411: The Impact of Patient-reported Outcomes on Boolean 2.0 Remission Criteria in Rheumatoid Arthritis Patients in Real Clinical Practice -a Multicenter Observational Study: T-FLAG Study-Location: Poster Hall
Abstract Poster Presenter: – Nagoya University Graduate School of Medicine
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0412: COVID Antibody Response to Third Dose Anti-SARS-COV2 mRNA Vaccine in Patients with Seropositive Rheumatoid Arthritis on Immunosuppressive TherapyLocation: Poster Hall
Abstract Poster Presenter: – Ohio State University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0413: Transcriptomic Analysis of Peripheral Blood Mononuclear Cells Reveals Pain and Inflammation Specific Alterations in Difficult-to-treat Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Pécs; Semmelweis University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0414: Association of a Treat-to-Target Management Approach with Physician and Patient Reported Outcomes Among Real - World Patients with Rheumatoid Arthritis Receiving Advanced Therapy in EuropeLocation: Poster Hall
Abstract Poster Presenter: – Waikato Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0415: Serious Infections Hospital Admissions and Mortality in Patients with Early Inflammatory Arthritis: Results from a Large UK CohortLocation: Poster Hall
Abstract Poster Presenter: – King's College London
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0416: Association Between Sleep Disorders and Rheumatoid Arthritis: A Population-based Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Mayo Clinic
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0417: The Role of Rheumatoid Arthritis Flare in the Risk of Alzheimer’s Disease and Related Dementias: A Population-based Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Mayo clinic, Rochester, MN
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0418: Synovial Fluid Cell Counts Associated with Joint Histopathology in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Vanderbilt University School of Medicine
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0419: No Clinically Relevant Changes in Coagulation Activation Between Patients Initiating TNF-blockers versus JAK-inhibitorsLocation: Poster Hall
Abstract Poster Presenter: – Reade
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0420: Associations and Mortality Impact of Machine Learning-derived Quantitative Computed Tomography Parenchymal Lung Features in Rheumatoid Arthritis and non-RA Comparators in a Multicenter Prospective Cohort of SmokersLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0421: Bioinformatics Platform to Study the Genetics of Biologic DMARD Non-responders: Design and Protocol of the RA Non-responders to Treatment (RANT) StudyLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0422: Electronic Health Record-Based Machine Learning Model for Predicting Disease Activity in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Peking University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0423: Detection of Citrullinated Proteins Recognized by a Novel Chimeric Antigen Receptor TregTherapy in Both Synovial Fluid and Serum from Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Sonoma Biotherapeutics
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0424: Real-World Effectiveness of Upadacitinib in Patients with Moderate/Severe Rheumatoid Arthritis: 6-Month Data from the Observational UPHOLD StudyLocation: Poster Hall
Abstract Poster Presenter: – Abbvie, Inc
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0425: Long-term Safety of Rituximab in Rheumatoid Arthritis: A Systematic Review and Meta-analysisLocation: Poster Hall
Abstract Poster Presenter: – King's College London
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0426: The Clinical Efficacy of Switching Therapy Between Biological Agents and JAK Inhibitors in the Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Osaka Metropolitan University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0427: Molecular Characterization of Biologic and Targeted Synthetic DMARDs Effects Through Ex- vivo Studies in Rheumatoid Arthritis Immune CellsLocation: Poster Hall
Abstract Poster Presenter: – IMIBIC - Reina Sofia Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0428: Real World Patterns of Advanced Therapy Tapering in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis CohortLocation: Poster Hall
Abstract Poster Presenter: – University of Calgary
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0429: Direct and Indirect Effects of Upadacitinib or Adalimumab on Pain in Rheumatoid Arthritis: Results from a Randomized Phase 3 StudyLocation: Poster Hall
Abstract Poster Presenter: – University of Oxford
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0430: A Multicenter, Real-world Clinical Data Study of the Use of JAK Kinase Inhibitors in a Large Cohort of Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Hospital Vall d´Hebron
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0431: Senescence and Cell Exhaustion in CD4+ and CD8+ Lymphocytes in Rheumatoid Arthritis Patients in Remission Without TreatmentLocation: Poster Hall
Abstract Poster Presenter: – INCMNSZ
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0432: Predictors of Use, Survival and Safety of Tofacitinib Monotherapy vs. in Combination with CsDMARDs in Daily Clinical PracticeLocation: Poster Hall
Abstract Poster Presenter: – Hospital Avellaneda
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0434: Effects of B/tsDMARDs on Non-inflammatory Pain in Patients with Rheumatoid Arthritis -ANSWER Longitudinal Cohort Study-Location: Poster Hall
Abstract Poster Presenter: – Kobe-University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0435: Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following Release of Safety DataLocation: Poster Hall
Abstract Poster Presenter: – Southland Arthritis
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0436: Patients with Difficult-to-treat Rheumatoid Arthritis Have Higher Levels of Inflammation on UltrasoundLocation: Poster Hall
Abstract Poster Presenter: – University of Ottawa
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0437: Comparative Safety of Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for Cardiovascular Outcomes in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Washington
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0438: Association Between Methotrexate Use and Lymphoma in Rheumatoid Arthritis: A Systematic Literature ReviewLocation: Poster Hall
Abstract Poster Presenter: – University of Utah
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0439: Humoral Immune Response to 13 Valent-conjugate and 23-valent Polysaccharide Pneumococcal Vaccines in RA Patients Treated with Abatacept: Results of the Open Randomized Controlled Trial VACINA (Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients)Location: Poster Hall
Abstract Poster Presenter: – CHU and University of Montpellier
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0440: Baseline T Cell and B Cell-related Markers and HLA-DRB1 Shared Epitope Alleles Predict the Therapeutic Efficacy of Abatacept in Patients with Moderate to Severe Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Washington
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0441: Outcomes in Patients with Rheumatoid Arthritis Initiating Therapy with Etanercept, Adalimumab, or Janus Kinase InhibitorsLocation: Poster Hall
Abstract Poster Presenter: – University of Pennsylvania
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0442: Infliximab Clearance a Predictive Factor of Pharmacokinetic Origin in Relation to Suboptimal Pharmacokinetics and Immunogenicity in United States Based Rheumatology PracticesLocation: Poster Hall
Abstract Poster Presenter: – Institute for Rheumatic & Autoimmune Diseases--Atlantic Health System
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0443: The Potential of an Oral TNFα Inhibitor with TNFR1 Specificity: Results of a Phase 1b Proof-of-mechanism Trial in PsoriasisLocation: Poster Hall
Abstract Poster Presenter: – Sanofi
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0444: Safety, Tolerability, and Pharmacokinetics of a Novel Synthetic Disease Modifying Antirheumatic Drug, TCK-276, After Single Ascending Dose in Healthy Subjects and Multiple Ascending Doses in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Teijin pharma limited
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0445: Comparison of the Efficacy, Safety and Immunogenicity of a Proposed Biosimilar MSB11456 with Tocilizumab Reference Product in Moderate-to-severe Rheumatoid Arthritis: Results of a Randomized Double-blind StudyLocation: Poster Hall
Abstract Poster Presenter: – Fresenius Kabi SwissBioSim
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0446: Review of Rheumatoid Arthritis Treatment Landscape During the COVID-19 PandemicLocation: Poster Hall
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0447: Glucocorticoid Use in Rheumatoid Arthritis Patients Initiating Biological or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs (b/tsDMARDs) in Real Life: Data from BIOBADASERLocation: Poster Hall
Abstract Poster Presenter: – Hospital Gregorio Marañón
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0448: Cardioprotective Impact of JAKi, Tofacitinib, on CV Risk in Rheumatoid Arthritis: JAKi CV Risk Impact StudyLocation: Poster Hall
Abstract Poster Presenter: – Healing Touch City Clinic
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0449: Parsing Pathophysiology of Rheumatoid Arthritis-associated Lymphoproliferative Disorders via Whole RNA Transcriptome Analysis: Multi-center Study in JapanLocation: Poster Hall
Abstract Poster Presenter: – Osaka Minami Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0450: Baricitinib versus TNF-inhibitors in Patients with Active Rheumatoid Arthritis After Failure of CsDMARDs: A Pragmatic, Multicenter, Real-Life Study in a Treat-to-Target SettingLocation: Poster Hall
Abstract Poster Presenter: – University of Twente
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0451: Long-term Clinical Profile of Filgotinib in Patients with Rheumatoid Arthritis by Cardiovascular Risk Factors: A Post Hoc Subgroup AnalysisLocation: Poster Hall
Abstract Poster Presenter: – UNIVERSITY OF MANCHESTER
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0452: Real Life Safety and Survival of Targeted Therapies in Arthritis Patients over Age of 65Location: Poster Hall
Abstract Poster Presenter: – HUP La Fe
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0453: Risk of Lung Cancer in Veterans with Rheumatoid Arthritis in Relation to Use of Conventional versus Biologic or Targeted Synthetic DMARDsLocation: Poster Hall
Abstract Poster Presenter: – University of Washington
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0454: Rheumatoid Arthritis Disease Activity Indices Assess More Than Inflammation: 29%-36% of Patients with Moderate or High DAS28–ESR or CDAI Have 0 or 1 Swollen Joints, but Positive Screens on MDHAQ FAST4 (fibromyalgia Assessment Screening Tool) And/or MDS2 (MDHAQ Depression Screen) IndicesLocation: Poster Hall
Abstract Poster Presenter: – Rush University Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0455: Rosnilimab, a Novel PD-1 Agonist Monoclonal Antibody, Inhibits Peripheral T Cell Proliferation and Cytokine Secretion and Reduces Circulating PD-1 High Expressing CD4 and CD8 T Cells: Results from a Phase 1 Healthy Volunteer Clinical TrialLocation: Poster Hall
Abstract Poster Presenter: – AnaptysBio
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0456: The “Topics” in the Electronic Health Record of Rheumatoid Arthritis Patients Before Initiating Targeted Therapies and Association with Future Treatment CourseLocation: Poster Hall
Abstract Poster Presenter: – Harvard College
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0457: Biologic Disease Modifying Antirheumatic Drug Use in Immune Checkpoint Inhibitor-Treated Cancer Patients with Rheumatoid Arthritis: Utilization and Overall SurvivalLocation: Poster Hall
Abstract Poster Presenter: – Hospital For Special Surgery
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0458: Drug Switching Due to Inefficacy in Rheumatoid Arthritis Patients Treated with Biological and Targeted Therapies. Daily Clinical ExperienceLocation: Poster Hall
Abstract Poster Presenter: – Hospital Clinico San Carlos
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
9:00 AM – 11:00 AM PT0459: Upadacitinib Monotherapy versus Methotrexate in Patients with Rheumatoid Arthritis: Efficacy and Safety Through 5 Years in the SELECT-EARLY Randomized Controlled TrialLocation: Poster Hall
Abstract Poster Presenter: – Stanford University School of Medicine, Palo Alto CA
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
11:45 AM – 11:55 AM PT0724: Synovial Macrophage Subsets Defined by ScRNAseq Demonstrate Sexually Dimorphic Gene Expression in RA and a Mouse Inflammatory Arthritis ModelLocation: Exhibit Hall A-B
Plenary Presenter: – Hospital for Special Surgery
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
12:00 PM – 1:00 PM PT12S127: No Pain and Much to Gain: Mechanisms and Targets of Pain in Rheumatic DiseasesLocation: Room 29A-D
Moderator: – Icahn School of Medicine at Mount Sinai
Moderator: – Rush University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
12:00 PM – 12:15 PM PTBiomechanical Pathways of Pain in OA: Experimental Evidence from Translational Mouse ModelsLocation: Room 29A-D
Speaker: – Rush University Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
12:15 PM – 12:30 PM PTNovel Ligands and Receptors in Pain MechanismsLocation: Room 29A-D
Speaker: – University of Texas, Dallas
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
12:30 PM – 12:45 PM PTNeuroinflammation and Immunotherapy in PainLocation: Room 29A-D
Speaker: – Duke University School of Medicine
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
12:45 PM – 1:00 PM PTQ&ALocation: Room 29A-D
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
2:00 PM – 3:30 PM PT12S147: Abstracts: RA – Diagnosis, Manifestations, & Outcomes I: RA-ILD (0769–0774)Location: Room 6E/6D
Abstract Moderator: – University of Pennsylvania
Abstract Moderator: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
2:00 PM – 2:10 PM PT0769: Development and Validation of a Combined Clinical and Genetic Risk Score for Interstitial Lung Disease in a Large, Multicenter, Prospective Rheumatoid Arthritis CohortLocation: Room 6E/6D
Presenting Author: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
2:15 PM – 2:25 PM PT0770: Plasma Matrix Metalloproteinases in Rheumatoid Arthritis-Interstitial Lung Disease: Associations with Disease Presence, Severity, and SubtypesLocation: Room 6E/6D
Presenting Author: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
2:30 PM – 2:40 PM PT0771: A Modified Idiopathic Pulmonary Fibrosis-Derived Composite Biomarker Score Is Associated with Interstitial Lung Disease Among U.S. Veterans with Rheumatoid ArthritisLocation: Room 6E/6D
Presenting Author: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
2:45 PM – 2:55 PM PT0772: MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseLocation: Room 6E/6D
Presenting Author: – University of Nebraska Medical Center College of Medicine
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
3:00 PM – 3:10 PM PT0773: Sputum Lautropia Abundance Is Decreased in Rheumatoid Arthritis-Associated Pulmonary Fibrosis and Correlates with Lung Disease SeverityLocation: Room 6E/6D
Presenting Author: – Thomas Jefferson University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
3:15 PM – 3:25 PM PT0774: Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Phenotypes Using Unsupervised Hierarchical Clustering Analysis: Results from a Large Collaborative International StudyLocation: Room 6E/6D
Presenting Author: – Division of Rheumatology, Inflammation, and Immunity Brigham & Women’s Hospital
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:00 PM – 5:30 PM PT12S165: Abstracts: RA – Animal Models (0793–0798)Location: Room 32A-B
Abstract Moderator: – Northwestern University
Abstract Moderator: – ucsd
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:00 PM – 5:30 PM PT12S166: Abstracts: RA – Treatments I: Novel RA Treatments & Mechanisms of Action (0835–0840)Location: Room 6E/6D
Abstract Moderator: – Massachusetts General Hospital
Abstract Moderator: – Columbia University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:00 PM – 4:10 PM PT0793: The Dual Specificity Phosphatase 6 (DUSP6) Regulates Arthritis Severity and IL10 ProductionLocation: Room 32A-B
Presenting Author: – Icahn school of Medicine at Mount Sinai
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:00 PM – 4:10 PM PT0835: Abatacept in Individuals at Risk of Developing Rheumatoid Arthritis: Results from the Arthritis Prevention in the Pre-clinical Phase of RA with Abatacept (APIPPRA) TrialLocation: Room 6E/6D
Presenting Author: – King's College London
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:15 PM – 4:25 PM PT0794: Microbiota-dependent Indole Production Is Required for the Development of Collagen-induced ArthritisLocation: Room 32A-B
Presenting Author: – University of Colorado
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:15 PM – 4:25 PM PT0836: Vagotomy and Subsequent Risk of Rheumatoid Arthritis and Osteoarthritis: A Danish Register-Based Cohort StudyLocation: Room 6E/6D
Presenting Author: – Stanford University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:30 PM – 4:40 PM PT0795: The Focal Adhesion Protein Lasp1 Links the Arp2/3 Complex to Cell-to-cell Contact Formation in Arthritic Fibroblast-like SynoviocytesLocation: Room 32A-B
Presenting Author: – University Hospital Muenster
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:30 PM – 4:40 PM PT0837: A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid ArthritisLocation: Room 6E/6D
Presenting Author: – Stanford University
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:45 PM – 4:55 PM PT0796: Role of Group 2 Innate Lymphoid Cells in the Pathogenesis of Rheumatoid ArthritisLocation: Room 32A-B
Presenting Author: – University of Gothenburg
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
4:45 PM – 4:55 PM PT0838: Infusion of Etanercept into the Peripheral Lymphatics Significantly Reduces Disease Activity in Rheumatoid Arthritis Patients with Inadequate Response to Subcutaneous InjectionsLocation: Room 6E/6D
Presenting Author: – Sorrento Therapeutics
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
5:00 PM – 5:10 PM PT0797: Innate Lymphoid Cells Enhance Development of CD4+ T-cell Driven Autoimmune ArthritisLocation: Room 32A-B
Presenting Author: – University of Gothenburg
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
5:00 PM – 5:10 PM PT0839: Efficacy and Safety of Nipocalimab in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA): The Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2a IRIS-RA StudyLocation: Room 6E/6D
Presenting Author: – University of Oxford
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
5:15 PM – 5:25 PM PT0798: A Novel 3D Model of Rheumatoid Arthritis Synovial Tissue Incorporating Fibroblasts, Endothelial Cells and MacrophagesLocation: Room 32A-B
Presenting Author: – Amsterdam UMC, locatie AMC
Rheumatoid arthritis (RA)
-
Sunday, Nov 12th
5:15 PM – 5:25 PM PT0840: Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Final Results from a Phase IIa StudyLocation: Room 6E/6D
Presenting Author: – Peking Union Medical College Hospital Department of Rheumatology and Clinical Immunology
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
7:30 AM – 9:00 AM PT13M108: Evidenced-based RA: The Key Lessons Learned from Worldwide RegistriesLocation: Ballroom 20D
Moderator: – Royal Adelaide Hospital and University of Adelaide
Moderator: – University of Washington
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
7:30 AM – 7:50 AM PTUnited States Veterans: A Summary of Key Treatment and Co-morbidity Considerations from the VARA RegistryLocation: Ballroom 20D
Speaker: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
7:50 AM – 8:00 AM PTQ&ALocation: Ballroom 20D
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
8:00 AM – 8:20 AM PTThe Efficacy of RA TherapeuticsLocation: Ballroom 20D
Speaker: – Rigshospitalet
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
8:20 AM – 8:30 AM PTQ&ALocation: Ballroom 20D
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
8:30 AM – 8:50 AM PTIORRA: Contextualized Safety Data of Rheumatoid Arthritis TherapeuticsLocation: Ballroom 20D
Speaker: – Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University School of Medicine
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
8:50 AM – 9:00 AM PTQ&ALocation: Ballroom 20D
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT(1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster IILocation: Poster Hall
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT(1308–1344) RA – Treatment Poster IILocation: Poster Hall
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1258: “What Is My Risk Really?”: A Qualitative Exploration and Ideal-Type Analysis of Preventive Interventions Among Individuals at Risk of Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Leeds
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1261: Network Analysis of Depression and Anxiety Symptoms in Chinese Rheumatoid Arthritis PatientsLocation: Poster Hall
Abstract Poster Presenter: – Shanghai jiaotong university
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1264: Nomination of Biomarkers for Self-testing Disease Activity in Rheumatoid Arthritis Using Patient Similarity Networks: A Pilot StudyLocation: Poster Hall
Abstract Poster Presenter: – University Hospital Olomouc
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1265: Changes in the Endocannabinoid Tone in Rheumatoid Arthritis and Osteoarthritis – Discovery of a Novel Target for the Treatment of Pain and Inflammation?Location: Poster Hall
Abstract Poster Presenter: – University of Colorado
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1266: The Anti-inflammatory Effect of High-density Lipoprotein Is Blunted by Delivery of Altered MicroRNA Cargo to Macrophages in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Vanderbilt University Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1267: Lower Herpes Zoster Rate of Tocilizumab and Tofacitinib in Patients Undergoing Treatment for Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Chang-Gung memorial hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1268: Clinical Characteristics of Patients with Rheumatoid Arthritis (RA) Who Rate Their Global Assessment of Disease Activity Substantially Lower Than Their Physicians (Negative Discordance) Based on a Large RA Database in Japan: A Rare but Important SubgroupLocation: Poster Hall
Abstract Poster Presenter: – Tokyo Medical University Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1269: The Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-associated Interstitial Lung Disease SubtypesLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1270: Identification of Subclinical Atherosclerosis by Six Cardiovascular Risk Calculators in Rheumatoid Arthritis PatientsLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario "Dr. Jose E. Gonzalez", Monterrey, Mexico
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1271: Upregulation of IFNγ-Response Genes in Monocytes and T Cells Identified by Single-Cell Transcriptomics in Patients with Anti-CCP Antibody-Positive Rheumatoid Arthritis (RA)Location: Poster Hall
Abstract Poster Presenter: – HoYoun Kim’s Clinic for Arthritis Rheumatism
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1272: Immunomodulators and Risk for Breakthrough COVID-19 After a Third SARS-CoV-2 mRNA Vaccine Among Patients with Rheumatoid Arthritis: A Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1273: Long-term Follow-up of Treated-to-target RA and UA: Results of the BeSt and IMPROVED StudiesLocation: Poster Hall
Abstract Poster Presenter: – LUMC
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1274: Rheumatoid Arthritis Patients, Achieving Low Disease Activity State or Remission, Still Demonstrate Significant Hand Disability, as Assessed by Functional Dexterity Test: A Disconnection Between CDAI and Functional Hand AssessmentLocation: Poster Hall
Abstract Poster Presenter: – Bnai Zion Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1275: Prevalence of Frailty Among Individuals Living with Rheumatoid Arthritis: A Population-based Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Dalhousie University
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1276: Multimorbidity Burden Predicts Lower Likelihood of Remission in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Mayo Clinic
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1277: Relationship Between Quality of Life and the Region of the Affected Joints in Japanese Patients with Rheumatoid Arthritis: A Cross-sectional StudyLocation: Poster Hall
Abstract Poster Presenter: – Japanese Red Cross Kumamoto Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1278: Nature and Severity of Activity Limitations According to the Health Assessment Questionnaire Disability Index in Patients with Rheumatoid Arthritis and Functional DisabilityLocation: Poster Hall
Abstract Poster Presenter: – Leiden University Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1279: What Is the Nature of Functional Problems in People with Rheumatoid Arthritis and Severe Disability; An Analysis Using the International Classification of Functioning, Disability and Health as a ReferenceLocation: Poster Hall
Abstract Poster Presenter: – Leiden University Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1280: Systemic Inflammation Is Associated with Incident Valvular Heart Disease in Patients with Rheumatoid Arthritis: A Multicenter, Prospective Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1281: Risk of Cancer in Patients with Rheumatoid Arthritis Under Tocilizumab: Data from the French National Registry REGATELocation: Poster Hall
Abstract Poster Presenter: – CHU and University of Montpellier
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1282: Proteomic Signature in Peripheral Blood and Sputum in Rheumatoid Arthritis Patients with and Without Lung InvolvementLocation: Poster Hall
Abstract Poster Presenter: – Lund University and Skåne University Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1283: Atherogenic Index of Plasma Identifies Patients with Rheumatoid Arthritis and Increased Carotid Intima-Media ThicknessLocation: Poster Hall
Abstract Poster Presenter: – Universidad Autónoma de Nuevo León
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1284: Baseline Data's Role in Predicting All-cause Mortality in Chinese Rheumatoid Arthritis Patients: Findings from the China Registry of Rheumatoid Arthritis (CREDIT) StudyLocation: Poster Hall
Abstract Poster Presenter: – Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1285: PROMIS Symptom Clusters Predict Disease Activity in the First 6 Months in Newly Diagnosed RA Patients Starting MTX Therapy: Data from the Canadian Early Arthritis CohortLocation: Poster Hall
Abstract Poster Presenter: – McGill University
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1286: Impact of Body Mass Index (BMI) on Upper versus Lower Extremity Joints Assessed Using Clinical and Musculoskeletal Ultrasound Measures in Rheumatoid Arthritis PatientsLocation: Poster Hall
Abstract Poster Presenter: – University of California
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1287: Impact of Body Mass Index (BMI) on Rheumatoid Arthritis Disease Activity and Musculoskeletal Ultrasound MeasuresLocation: Poster Hall
Abstract Poster Presenter: – University of California
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1288: Frailty Is Associated with Higher Risk of Readmission in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Washington
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1289: Increases in Serum Levels of Tartrate-Resistant Acid Phosphatase 5b Reflected Radiographic Progression of Joint Damage in Treated Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Dokkyo Medical University Saitama Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1290: Development of a Genetic Risk Score for Pain in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Boston University
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1291: Risk Factors for Major Adverse Cardiovascular Events and Malignancies in Patients with Rheumatoid Arthritis in a Real-World Setting in JapanLocation: Poster Hall
Abstract Poster Presenter: – Kitasato University School of Medicine
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1292: Active Rheumatoid Arthritis Patients Exhibit an Altered Serum Lipidomic Profile Directly Linked to Disease Activity, Which Is Reversed by Biologic and Targeted Synthetic DMARDLocation: Poster Hall
Abstract Poster Presenter: – IMIBIC - Reina Sofia Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1293: Single Camera Hand Motion Capturing as a Digital Biomarker for Disease Activity in Rheumatoid Arthritis Using Computer Vision: The Proof-of-Concept MeFisto StudyLocation: Poster Hall
Abstract Poster Presenter: – University Hospital Lausanne
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1294: Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: Using Rasch Measurement Theory and Cognitive Interviewing to Achieve More Meaningful MeasurementLocation: Poster Hall
Abstract Poster Presenter: – Cardiff University
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1295: Having More Tender Than Swollen Joints Is Associated with Worse Functional Outcomes in Patients with Early RA in a Prospective Real-World CohortLocation: Poster Hall
Abstract Poster Presenter: – Hospital for Special Surgery
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1296: Decline in Incidence of Extraarticular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Mayo Clinic Rochester
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1297: COVID-19 Vaccination-related Delayed Adverse Events Among Patients with Rheumatoid Arthritis: Results from the COVAD StudyLocation: Poster Hall
Abstract Poster Presenter: – Centre for Rheumatic Diseases, King's College London
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1298: Risk Factors Associated with Venous Thromboembolism in Rheumatoid Arthritis in Clinical PracticeLocation: Poster Hall
Abstract Poster Presenter: – APHP - Cochin hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1299: Rheumatoid Arthritis Patients Who Never Use a Biological During Their Disease Course Represent a Subgroup of Patients Likely to Achieve Sustained DMARD-free RemissionLocation: Poster Hall
Abstract Poster Presenter: – ErasmusMC
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1300: Bone Marrow Edema in MRI Is More Associated with Rapid Radiographic Progression Than Clinically Relevant Radiographic ProgressionLocation: Poster Hall
Abstract Poster Presenter: – Katayama Orthopedic Rheumatology Clinic
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1301: The Relationship Between Socioeconomic Factors and Persistent Active Rheumatoid Arthritis: Results from (NEIAA) a Large UK Cohort of Early Inflammatory ArthritisLocation: Poster Hall
Abstract Poster Presenter: – King's College London
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1302: Biomarkers of Cardiovascular Risk in Patients with Rheumatoid Arthritis: Results from the TARGET Trial Biomarker StudyLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1303: Patient’s and Physician’s Evaluation of Global Assessment of Disease Activity over Follow up and Across Disease Activity Levels in Recent-Onset Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Université de Montréal
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1304: Window of Opportunity to Achieve Better Functional Outcomes in Patients with RA: Effectiveness of an Early Treatment StrategyLocation: Poster Hall
Abstract Poster Presenter: – Hospital for Special Surgery
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1305: Variations in Macrophage Cholesterol Loading over Time Are Linked to Dynamic Changes in Coronary Atherosclerotic Plaque in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1306: Statin Use Attenuates the Impact of Systemic Inflammation on Ischemic Cardiovascular Risk in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1307: Impact of Comorbidities on the First bDMARD Effectiveness and Retention Rate After 2 Years of Follow-up in Patients with Rheumatoid Arthritis. Data from the Spanish Registry BIOBADASERLocation: Poster Hall
Abstract Poster Presenter: – Reina Sofia University Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1308: Certolizumab Pegol Shows Longer Retention Rate in Comparison with Other TNF Inhibitors in Patients with Rheumatoid Arthritis and High Rheumatoid Factor Titers at Baseline. a Multicentre and Retrospective StudyLocation: Poster Hall
Abstract Poster Presenter: – Reina Sofia University Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1309: Refractory RA Patients for Targeted Therapies in Real LifeLocation: Poster Hall
Abstract Poster Presenter: – HUP La Fe
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1310: Comparison of Two Methotrexate Initiation Strategies in Rheumatoid Arthritis in Current PracticeLocation: Poster Hall
Abstract Poster Presenter: – Bellvitge University Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1311: T Cell Subset Signatures Predicted Clinical Response to Etanercept-biosimilar Yisaipu in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Peking University Peoples'Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1312: Uncovering Risk Factors for Adverse Events and Infections in Rheumatoid Arthritis and Rheumatoid Arthritis with Interstitial Lung Disease Under Biologics or Targeted Synthetic DMARDs: Insights from the KOBIO RegistryLocation: Poster Hall
Abstract Poster Presenter: – Ajou university school of medicine
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1313: Remotely Supervised Weight Loss and Exercise Training Improves Disease Activity and Patient Reported Outcomes in Older Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Duke University
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1314: Safety Results from a Phase 1 Double-blind Randomized Clinical Trial of Allogeneic Mesenchymal Stem Cells in Early RALocation: Poster Hall
Abstract Poster Presenter: – The MetroHealth System at Case Western Reserve University School of Medicine
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1315: Elevated Serum Adiponectin Levels During Olokizumab Treatment in Patients with Rheumatoid Arthritis Correlate with High-density Lipoprotein Lipid Profile Independently of Body Mass Index: Results from the Double-blind, Randomized Controlled Phase III StudiesLocation: Poster Hall
Abstract Poster Presenter: – R-Pharm
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1316: Influence of Rheumatoid Factor on Serum Drug Levels of TNF Inhibitors with Different Structures in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario La Paz
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1317: Discontinuation of Biological Disease Modifying Drugs Due to Adverse Drug Reactions in an Inception Rheumatoid Arthritis CohortLocation: Poster Hall
Abstract Poster Presenter: – Hospital Clínico San Carlos
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1318: Abatacept Modulates Both Global and Citrulline Specific T Cell Signatures: Results from Inhibition of Co-Simulation in Rheumatoid Arthritis Phase IV TrialLocation: Poster Hall
Abstract Poster Presenter: – Karolinska Institutet
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1319: Real World Data on Antifibrotics in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 73 PatientsLocation: Poster Hall
Abstract Poster Presenter: – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1320: Evaluation of Circulating Levels of Helper T and Innate Lymphoid Cells Subsets in a Cohort of bDMARDs-naïve Patients with Rheumatoid Arthritis Treated with AbataceptLocation: Poster Hall
Abstract Poster Presenter: – ASST Spedali Civili and University of Brescia
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1321: Effect of Subcutaneous Local Anaesthesia Prior to Intra-Articular Injection: An Open Label, Paired-group, Randomized Controlled TrialLocation: Poster Hall
Abstract Poster Presenter: – PGIMER, CHD, INDIA
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1322: Efzofitimod, a First-in Class NRP2-targeting Immunomodulator, Ameliorates Rheumatoid Arthritis and Associated Lung Fibrosis in Preclinical ModelsLocation: Poster Hall
Abstract Poster Presenter: – aTyr Pharma
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1323: Distinct Treatment Responses in Patients with Rheumatoid Arthritis Receiving Filgotinib 200 Mg over 12 Months: A Post Hoc Analysis of FINCH 1Location: Poster Hall
Abstract Poster Presenter: – University of Oxford
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1324: Previous History of Serious Infection Is Associated with the Use of IL-6 Inhibitors in Rheumatoid Arthritis in Wales, UKLocation: Poster Hall
Abstract Poster Presenter: – Cardiff University
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1325: Integrated Safety Analysis of Filgotinib in Patients with Moderate to Severe Active Rheumatoid Arthritis with a Maximum Exposure of 8.3 YearsLocation: Poster Hall
Abstract Poster Presenter: – Oregon Health & Science University
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1326: Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 204 from the SELECT-CHOICE StudyLocation: Poster Hall
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1327: Effects of Long-Term Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis on Body Weight and Blood Pressure: A Pooled Analysis of Individual Patient Data from Five Randomised TrialsLocation: Poster Hall
Abstract Poster Presenter: – Charité - Universitätsmedizin Berlin
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1328: Switching Biologics or Janus Kinase Inhibitors Is Effective in Difficult-to-treat Rheumatoid Arthritis, Regardless of InflammationLocation: Poster Hall
Abstract Poster Presenter: – Osaka Metropolitan Univ. Graduate School of Medicine, Baba Memorial Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1329: R851, a Potent Second Generation IRAK1 and IRAK4 Inhibitor Suppresses IL-6 in Vitro and in Vivo for the Treatment of Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Rigel Pharmaceuticals, Inc.
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1330: Certolizumab-pegol, Abatacept, Tocilizumab or Active Conventional Therapy in Early Rheumatoid Arthritis: 48 Week Patient-reported Outcomes of the NORD-STAR TrialLocation: Poster Hall
Abstract Poster Presenter: – Karolinska University Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1332: Patient-Reported Outcomes, Disease Activity and Safety in 798 Patients with RA Treated with Filgotinib: Up to 1-Year Interim Results from a Prospective Observational Study (FILOSOPHY)Location: Poster Hall
Abstract Poster Presenter: – EULAR
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1333: Rheumatoid Arthritis-associated Lymphoproliferative Disorders: A Multi-center Analysis of Clinical Outcomes and Evaluation of Anti-rheumatic Drugs After LPD OnsetLocation: Poster Hall
Abstract Poster Presenter: – National Hospital Organization Osaka Minami Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1334: Comparison of Malignancies and Serious Infections Between Etanercept Biosimilar and Bio-Originator Initiators: Population-Based AnalysesLocation: Poster Hall
Abstract Poster Presenter: – University of Alberta
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1335: Effectiveness of Longstanding Exercise Therapy versus Usual Care in People with Rheumatoid Arthritis and Severe Functional Limitations: A Randomized Controlled Trial (L-EXTRA)Location: Poster Hall
Abstract Poster Presenter: – Leiden University Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1336: Adalimumab and Etanercept Serum Levels in Rheumatoid Arthritis Patients with and Without a Disease Flare During TaperingLocation: Poster Hall
Abstract Poster Presenter: – ErasmusMC
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1337: Effect of Tofacitinib Therapy on Angiotensin Converting Enzyme Activity in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Debrecen
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1338: The Advantage of Tight Control and Treat-to-Target in New-onset Rheumatoid Arthritis Patients in Daily Rheumatology Practice: Results from a Contemporary University Clinic Inception CohortLocation: Poster Hall
Abstract Poster Presenter: – Department of Rheumatology, Skane University Hospital, Lund
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1339: Neutrophil Activation and Formation of Neutrophil Extracellular Traps Are Associated with Response to Abatacept in Patients with Moderate to Severe Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Washington
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1340: Recent Trends in Treatment Patterns for Rheumatoid Arthritis in Response to Emerging DataLocation: Poster Hall
Abstract Poster Presenter: – Southland Arthritis
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1341: Impact of Ultrasound on Physician Assessments of Patients with RA with Elevated Clinical Disease Activity ScoresLocation: Poster Hall
Abstract Poster Presenter: – Southland Arthritis
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1342: The Delivery of the Super-repressor IκBα by Exosomes Has the Potential to Alleviate Inflammation Associated with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Chonnam National University Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1343: Cardiovascular (CV) and Malignancy Events in the Filgotinib Rheumatoid Arthritis (RA) Clinical Development Program up to 8.3 YearsLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario Araba
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
9:00 AM – 11:00 AM PT1344: Efficacy and Safety of JAK Inhibitors in Difficult to Treat Rheumatoid Arthritis in Clinical PracticeLocation: Poster Hall
Abstract Poster Presenter: – APHP - Cochin Hospital
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
11:00 AM – 11:45 AM PT13M120: Meet the Panel: RALocation: Room 6A-B
Moderator: – The Corrona Research Foundation
Moderator: – Vanderbilt University Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
11:00 AM – 11:30 AM PTMeet the Panel: Rheumatoid ArthritisLocation: Room 6A-B
Panelist: – Johns Hopkins University
Panelist: – Hospital for Special Surgery
Panelist: – Berkshire Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
11:30 AM – 11:45 AM PTQ&ALocation: Room 6A-B
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
12:00 PM – 12:10 PM PT1583: Comparison of Two Dosing Schedules for Oral Methotrexate (Split-Dose versus Single-Dose) Once Weekly in Patients with Active Rheumatoid Arthritis: A Multicenter, Open Label, Parallel Group, Randomized Controlled Trial (SMART Study)Location: Exhibit Hall A-B
Plenary Presenter: – PGIMER, CHD, INDIA
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
12:00 PM – 1:00 PM PT13M127: Hench Memorial LectureLocation: Room 11A-B
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
12:00 PM – 12:45 PM PTAntigen Specific Therapy: Is It the Holy Grail for Autoimmunity?Location: Room 11A-B
Speaker: – Benaroya Research Institute at Virginia Mason
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
2:00 PM – 3:00 PM PT13M140: Precision Clinical Trial Design in Rheumatoid ArthritisLocation: Room 6A-B
Moderator: – Hospital for Special Surgery
Moderator: – Northwell Health
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
2:00 PM – 2:45 PM PTPrecision Clinical Trial Design in Rheumatoid ArthritisLocation: Room 6A-B
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
2:45 PM – 3:00 PM PTQ&ALocation: Room 6A-B
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
2:00 PM – 3:30 PM PT13M148: Abstracts: RA – Diagnosis, Manifestations, & Outcomes II: Comorbidities (1627–1632)Location: Ballroom 20D
Abstract Moderator: – University of Toronto - Toronto
Abstract Moderator: – Mayo Clinic
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
2:00 PM – 2:10 PM PT1627: Methotrexate Use Associates with Ischemic Cardiovascular Risk Reduction in Males but Not Females with Rheumatoid ArthritisLocation: Ballroom 20D
Presenting Author: – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
2:15 PM – 2:25 PM PT1628: The Impact of Cardiovascular and Cerebrovascular Disease on the Risk of Dementia in Rheumatoid Arthritis. a Mediation AnalysisLocation: Ballroom 20D
Presenting Author: – Mayo Clinic
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
2:30 PM – 2:40 PM PT1629: Persons with Rheumatoid Arthritis and Long COVID Had Worse Pre-COVID RA Symptoms and Worse Non-RA Symptoms, as Well as Higher Rates of Fibromyalgia Compared with COVID Infected Long COVID NegativeLocation: Ballroom 20D
Presenting Author: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
2:45 PM – 2:55 PM PT1630: Patient-Reported Fatigue Associated with Joint Histopathology in Rheumatoid ArthritisLocation: Ballroom 20D
Presenting Author: – Stony Brook Medicine
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
3:00 PM – 3:10 PM PT1631: Comparison of Peripheral Biomarker Profiles Across Unique Multimorbidity Patterns in Rheumatoid ArthritisLocation: Ballroom 20D
Presenting Author: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
3:15 PM – 3:25 PM PT1632: Incident Malignancies in Patients with Rheumatoid Arthritis in Daily Rheumatological CareLocation: Ballroom 20D
Presenting Author: – German Rheumatism Research Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
4:00 PM – 5:30 PM PT13M164: Abstracts: RA – Treatments II: RA Treatment Safety (1675–1680)Location: Exhibit Hall A-B
Abstract Moderator: – Vanderbilt University Medical Center
Abstract Moderator: – University of Colorado
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
4:00 PM – 4:10 PM PT1675: Survival in Patients with Rheumatoid Arthritis and Early Breast Cancer Treated with Tumor Necrosis Factor InhibitorsLocation: Exhibit Hall A-B
Presenting Author: – MD Anderson Cancer Center
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
4:15 PM – 4:25 PM PT1676: Tofacitinib Accelerates in Vitro Clot Formation and Delays Clot Lysis in Rheumatoid Arthritis Blood by Enhancement of Macrophage TLR4 Mediated Cytokine Responses- a New Angle on Thrombosis with JAKi in RheumatologyLocation: Exhibit Hall A-B
Presenting Author: – Medical doctor graduated in Rio de Janeiro State University, Internal Medicine resident in Sheba Medical Center Tel Hashomer, Experimental Rheumatology Fellow in University of Leeds, UK
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
4:30 PM – 4:40 PM PT1677: Two-week Break in Methotrexate Treatment and COVID-19 Vaccine Response. Results of the Vaccine Response on off Methotrexate (VROOM) Study, an Open Label, Prospective, Two-arm Parallel-group, Multi-center, Superiority, Randomized Controlled TrialLocation: Exhibit Hall A-B
Presenting Author: – University of Nottingham
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
4:45 PM – 4:55 PM PT1678: Comparative Safety of Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for Cancer in Rheumatoid ArthritisLocation: Exhibit Hall A-B
Presenting Author: – University of Washington
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
5:00 PM – 5:10 PM PT1679: Effects of Janus Kinase Inhibitor on TNF-a and IL-6-Induced Osteoclasts and RANKL-Induced Osteoclasts in Peripheral Blood Monocytes from Patients with Rheumatoid ArthritisLocation: Exhibit Hall A-B
Presenting Author: – Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University
Rheumatoid arthritis (RA)
-
Monday, Nov 13th
5:15 PM – 5:25 PM PT1680: What Trade-offs Are Acceptable to Rheumatoid Arthritis Patients During Treatment Selection?Location: Exhibit Hall A-B
Presenting Author: – SCHLOSSPARK KLINIK, University Medicine Berlin
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT(1713–1733) RA – Animal Models PosterLocation: Poster Hall
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT(1734–1775) RA – Etiology and Pathogenesis PosterLocation: Poster Hall
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT(2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster IIILocation: Poster Hall
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT(2141–2176) RA – Treatment Poster IIILocation: Poster Hall
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PTL07: 3-year Results of Tapering TNFi to Withdrawal Compared to Stable TNFi Among Rheumatoid Arthritis Patients in Sustained Remission: A Multicenter Randomized TrialLocation: Poster Hall
Late-Breaking Poster Presenter: – Diakonhjemmet Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PTL08: Early Clinical Development of CIT-013, a First in Class NETosis Inhibitor, in a Randomized Phase I Dose Escalation Study in Healthy Volunteers Demonstrating Potent Inhibition of LPS Induced Neutrophil Extracellular Trap FormationLocation: Poster Hall
Late-Breaking Poster Presenter: – Middelinc
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PTL09: Efficacy and Safety of LNK01001 in Chinese Patients with Moderate to Severe Active Rheumatoid Arthritis with an Inadequate Response to Conventional Synthetic DMARDs: 24-week Results from a Phase 2 TrialLocation: Poster Hall
Late-Breaking Poster Presenter: – Peking Union Medical College Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1713: Prevention of Arthritis Development by Mechanical Unloading Through Inhibition of CCL2 and YAP-mediated Inflammation in the Rat Adjuvant-induced Arthritis ModelLocation: Poster Hall
Abstract Poster Presenter: – University of Jean Monnet
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1714: Aberrant Myeloid Populations in the TNF-Transgenic Model of Pulmonary Hypertension Overexpress Interferon Pathways and Are Driven by TNFR1 SignalingLocation: Poster Hall
Abstract Poster Presenter: – University of Rochester
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1715: Androgen Treatment Exhibits a Protective Role Against Focal Erosions in TNF-Induced Inflammatory Arthritis in MiceLocation: Poster Hall
Abstract Poster Presenter: – University of Rochester School of Medicine and Dentistry
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1716: High-Throughput Semi-Automated Micro-CT Analysis Identifies the Cuboid Bone as a Sex-Dependent Biomarker of Inflammatory-Erosive Arthritis in TNF-Tg MiceLocation: Poster Hall
Abstract Poster Presenter: – University of Rochester School of Medicine and Dentistry
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1717: Endothelial Cell Sphingosine 1-Phophate Receptor 1 Restrains VE-cadherin Cleavage and Attenuates Experimental Inflammatory ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Hospital for Special Surgery
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1718: Longitudinal Quantification of Bone Erosions, Pulmonary Disease, Pain, Gait and Sarcopenia to Holistically Assess Decreased Ad Libitum Physical Activity and Effects of Exercise in the TNF-Transgenic Murine Model of Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Rochester Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1719: Exploring the Link Between Osteitis and Bone Microstructure Changes in Rheumatoid Arthritis: Role of JAK-STAT Signaling PathwayLocation: Poster Hall
Abstract Poster Presenter: – Graduate School of Medicine, Kyoto University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1720: Successful Treatment of Rheumatoid Arthritis in Mice Using Cenerimod, a Selective Modulator of the S1P1 Receptor, Demonstrates the Potential Benefits of S1P1 Receptor Immunomodulation for Rheumatic DiseasesLocation: Poster Hall
Abstract Poster Presenter: – Idorsia Pharmaceuticals Ltd.
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1721: The Therapeutic Effects of Gingival Mesenchymal Stem Cells and Their Exosomes in a Chimeric Model of Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – OSU
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1722: Fate-mapping of Synovial Monocytes and MacrophagesLocation: Poster Hall
Abstract Poster Presenter: – Northwestern University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1723: 3,3-dimethyl-1-butanol and Its Metabolite 3,3-dimethylbutyrate Ameliorate Arthritis Severity in CIA Independent of Choline TMA Lyase ActivityLocation: Poster Hall
Abstract Poster Presenter: – University of Colorado School of Medicine
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1724: Human Embryonic Stem Cell-derived Mesenchymal Stem Cells Attenuates Experimental Pulmonary Fibrosis Through Mitochondria Transfer Mediated Anti-apoptotic and Immunomodulatory EffectsLocation: Poster Hall
Abstract Poster Presenter: – Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine and Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1725: Distinct Perivascular and Intravascular Lymphatic Mast Cells and Their Role in Lymphatic Clearance, Joint Inflammation, and Bone Erosion in the TNF-Transgenic Murine Arthritis ModelLocation: Poster Hall
Abstract Poster Presenter: – University of Rochester
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1726: Therapeutic Effect of ICAM-1 Mimic on Experimental Axial SpondyloarthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Toronto
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1727: Arthritogenicity of Homocitrullinated Peptides in HLA-DRB1 Transgenic MiceLocation: Poster Hall
Abstract Poster Presenter: – Western University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1728: A Novel Animal Model for Investigating the Effect of HLA-DRB1 on AtherosclerosisLocation: Poster Hall
Abstract Poster Presenter: – Western University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1729: An Antibody-drug Conjugate of Anti-TNFα Antibody and a Novel Glucocorticoid Molecule Exerts Synergistic Anti-inflammatory Effects for Treatment of Autoimmune DiseasesLocation: Poster Hall
Abstract Poster Presenter: – Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1730: Gut Microbiota Dysbiosis Impact Autonomic Function in Rheumatoid Arthritis PatientsLocation: Poster Hall
Abstract Poster Presenter: – University hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1731: A Competitive Inhibitor of MOART Showed Potent Therapeutic Effects in a Mouse Model of Collagen-induced ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Gilo Foundation and Medpacto Inc.
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1732: Immunopathogenesis and Preclinical Trials in a Humanized Mouse Model of Rheumatoid Arthritis(RA)Location: Poster Hall
Abstract Poster Presenter: – GemPharmatech CO., Ltd.
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1733: Platelet-Derived Growth Factor Is a Mediator of Disease in an Animal Model of Rheumatoid-Associated Interstitial Lung DiseaseLocation: Poster Hall
Abstract Poster Presenter: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1734: Serum PDGF-BB Levels Correlate with Lung Fibrosis in Mice Injected with Malondialdehyde-Acetaldehyde and/or Citrulline Modified VimentinLocation: Poster Hall
Abstract Poster Presenter: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1735: An Unorthodox HLA-DRhiCD15+ ‘Hybrid’ Population in Rheumatoid Arthritis Characterized Using Spectral CytometryLocation: Poster Hall
Abstract Poster Presenter: – SUNY Upstate Medical University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1736: The Effect of Resolvin E1 and Resolvin D1 Specialised Pro-resolving Mediators on the Inhibition of OsteoclastogenesisLocation: Poster Hall
Abstract Poster Presenter: – University of Glasgow -School of Infection and Immunity
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1737: ACPA, Anti-CarP and AAPA Can Be Detected in Saliva, but Not in Feces of Seropositive Rheumatoid Arthritis Patients – Support for Mucosal Involvement in Specific Locations in RALocation: Poster Hall
Abstract Poster Presenter: – Leiden University Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1738: Identification of Homeostatic and Inflammatory Synovial Fibroblast Signatures in Synovial Tissue Biopsies of Healthy Controls and Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Trinity College Dublin
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1740: Exploring Disease-Associated DNA Methylome Alterations in Rheumatoid Arthritis: Potential Diagnostic and Prognostic BiomarkersLocation: Poster Hall
Abstract Poster Presenter: – IBIMA Plataforma BIONAND
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1741: The Occurrence and Phenotype of Autoreactive T Cells in the At-Risk Phase of Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Karolinska Institutet and Karolinska University Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1742: Sputum Citrullinated Proteins and Sputum Anti-Cit-S100A8/A9 IgG Antibodies Are Increased in Serum Anti-CCP-IgG Positive Individuals Who Developed RALocation: Poster Hall
Abstract Poster Presenter: – University of Colorado
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1743: Individuals At-risk for and with Rheumatoid Arthritis Have Elevated Fecal Concentrations of Arthritogenic Subdoligranulum didolesgii Correlating with CCP3 AntibodiesLocation: Poster Hall
Abstract Poster Presenter: – University of Colorado School of Medicine
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1744: Histological and Molecular Comparison in the Synovial Tissue of Patients with Active Rheumatoid Arthritis to RemissionLocation: Poster Hall
Abstract Poster Presenter: – JLU Campus KK
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1745: Chronic Inflammation and Collagen IV Fragment Canstatin Influence Rheumatoid Arthritis Synovial Fibroblast and Endothelial Cell Interactions in Vitro and in VivoLocation: Poster Hall
Abstract Poster Presenter: – JLU Campus KK
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1746: Smoking as a Risk Factor for Rheumatoid Arthritis: Exclusive Association with IgA AutoantibodiesLocation: Poster Hall
Abstract Poster Presenter: – Leiden University Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1747: A Newly Described Cytokine interleukin-40 Is Increased in the Serum of Individuals At-risk of Rheumatoid Arthritis and Induces an Inflammatory Response in Mononuclear CellsLocation: Poster Hall
Abstract Poster Presenter: – 1st Faculty of Medicine, Charles University and Institute of Rheumatology in Prague
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1748: Macrophage Extracellular Traps Require Peptidylarginine Deiminase 2 and 4 and Are a Source of Citrullinated Antigens Bound by Rheumatoid Arthritis AutoantibodiesLocation: Poster Hall
Abstract Poster Presenter: – UW-Madison
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1749: Fatty Acid Synthase Is a Critical Repressor of Ferroptosis in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – The Second Affiliated Hospital of Zhejiang University School of Medicine
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1750: Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast-Like Synoviocyte Inflammatory ResponsesLocation: Poster Hall
Abstract Poster Presenter: – Kobe University Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1751: Profiling of Anti-PAD IgG and IgA in Patients from the Head-to-head Adalimumab vs Abatacept Rheumatoid Arthritis AMPLE Trial and Matched Healthy ControlsLocation: Poster Hall
Abstract Poster Presenter: – Bristol Myers Squibb
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1752: Fibroblast Expression of Neurotransmitter Receptor HTR2A Associates with Inflammation in Rheumatoid Arthritis JointLocation: Poster Hall
Abstract Poster Presenter: – Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University (SJTUSM)
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1753: Acylcarnitine Enrichment Is a Characteristic of Rheumatoid Arthritis Fibroblast-Like Synoviocyte Metabolic FingerprintLocation: Poster Hall
Abstract Poster Presenter: – University of Gothenburg
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1754: Novel and Unique Rheumatoid Factors Cross-React with Viral Epitopes in COVID-19Location: Poster Hall
Abstract Poster Presenter: – University of Wisconsin Madison
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1755: Unique Pattern of Cadherin 6 Localization in Fibroblast-Like SynoviocytesLocation: Poster Hall
Abstract Poster Presenter: – UCSD
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1756: Circulating CD4+CD25+CD127-FoxP3+CD39+ T Cells Predict the Response to Methotrexate Across Basal Disease Activity Strata in Early Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario La Paz
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1757: Quantitative Assessment of Synovial Vascularity Using Power Doppler Index in Rheumatoid Arthritis and Psoriatic Arthritis Patients with High Disease ActivityLocation: Poster Hall
Abstract Poster Presenter: – National Institute of Geriatric Rheumatology and Rehabilitation
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1758: Identification of Circulating Autoantibodies Associated with ACPA Status in Early Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Fundación Profesor Novoa Santos
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1759: Runx1 Is a Key Transcription Factor That Drives Synovial Fibroblast Pathogenicity in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Birmingham
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1760: Methotrexate Augments the Release of Granulocyte-macrophage Colony-stimulating Factor from Activated Rheumatoid Arthritis Fibroblast-like Synoviocytes - Possible Consequences for Persistence of Joint InflammationLocation: Poster Hall
Abstract Poster Presenter: – University of Gothenburg
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1761: JAK/STAT Inhibition Modifies the Innate Lymphoid Cells 1 Immune Response in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Palermo
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1762: Single-cell RNA Sequencing Analysis and Immune Profiling of Antigen-specific T Cells in Patients with Rheumatoid Arthritis and Healthy ControlsLocation: Poster Hall
Abstract Poster Presenter: – Benaroya Research Institute at Virginia Mason
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1763: Asthma Severity Is Associated Increased Serum Anti-cyclic Antibody Level at Baseline and in Increase During Longitudinal Follow-upLocation: Poster Hall
Abstract Poster Presenter: – University of Kansas, Internal Medicine
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1764: Antibody Responses to Citrullinated Type II Collagen and Vimentin Modified with Malondialdehyde-Acetaldehyde Differ in Rheumatoid Arthritis and Rheumatoid Arthritis-Interstitial Lung DiseaseLocation: Poster Hall
Abstract Poster Presenter: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1765: Persistent Cigarette Smoking Is Associated with Rheumatoid Arthritis Onset and Neutrophil Activation in a Prospective Study of At-risk First-Degree RelativesLocation: Poster Hall
Abstract Poster Presenter: – University of Manitoba
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1766: Inflammatory Priming of the Joints via Pre-activation of Macrophages by Anti-MAA Antibodies in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Karolinska Institutet
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1767: TNF-α Utilizes the TWEAK/Fn-14 Axis in Human Rheumatoid Arthritis Synovial Fibroblasts to Induce InflammationLocation: Poster Hall
Abstract Poster Presenter: – Washington State University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1768: The Dynamics of the Gut Microbiome in Rheumatoid Arthritis Susceptibility: A Cross-Sectional and Longitudinal Observational StudyLocation: Poster Hall
Abstract Poster Presenter: – University of Leeds
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1769: TNF-Stimulated Production of IL-15 by Fibroblast-Like Synoviocytes Mediates Human Resident Memory T Cells Development in Synovial Organoid ModelLocation: Poster Hall
Abstract Poster Presenter: – Boston Children's Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1770: Dual Inhibition of TNF-α and OX40L on Synovial Inflammation and Osteoclastogenesis in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Seoul National University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1771: Role of Periostin in the Pathophysiology and Accurate Diagnosis of Interstitial Lung Disease Associated with Autoimmune DiseasesLocation: Poster Hall
Abstract Poster Presenter: – IDIVAL
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1772: Rheumatoid Arthritis-Specific Rheumatoid Factors Develop in Some COVID-19 PatientsLocation: Poster Hall
Abstract Poster Presenter: – University of Wisconsin-Madison
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1773: Integrated Analysis of Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS) Transcriptome and Chromatin Accessibility Identifies Mechanisms Associated with Location-specific Disease SeverityLocation: Poster Hall
Abstract Poster Presenter: – University of California San Diego
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1774: Gut Microbiota and Permeability Biomarkers for Diagnosis and Prognosis in Rheumatoid Arthritis Associated Interstitial Lung DiseaseLocation: Poster Hall
Abstract Poster Presenter: – University of Málaga
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT1775: The Peptidyl Arginine Deiminase Inhibitor BB-CLA Decreases the Inflammatory and Fibrotic Responses in Macrophages and Rheumatoid Arthritis Synovial Fibroblasts Exposed to Fibrinogen Modified with Malondialdehyde-Acetaldehyde Adduct and CitrullineLocation: Poster Hall
Abstract Poster Presenter: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2095: Integrated Analysis of Gene Expression and Methylation Identifies Biomarkers Associated with Mode of Action of Upadacitinib Treatment in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Glasgow
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2096: Association of Left Ventricular Mass with Interleukin-17 in Rheumatoid Arthritis Patients Without Clinical Heart FailureLocation: Poster Hall
Abstract Poster Presenter: – Columbia University Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2097: Comparing the World Health Organization and the American College of Cardiology/American Heart Association Algorithms for Detection of Carotid PlaqueLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario "Dr. Jose E. Gonzalez", Monterrey, Mexico
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2098: Contribution of Rare Deleterious Exonic Variants in Telomere Related Genes to Interstitial Lung Disease Risk in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Division of Rheumatology, Inflammation, and Immunity Brigham & Women’s Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2099: Lesser Impact of Lower-Small Joint Involvement on Pain Than Upper-Small Joint in Rheumatoid Arthritis: Analysis Based on a Large Rheumatoid Arthritis Database in JapanLocation: Poster Hall
Abstract Poster Presenter: – Tokyo Medical University Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2100: Paradoxical Antagonistic Association of Visceral and Subcutaneous Adipose Tissue with Circulating C-Reactive Protein in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Columbia University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2101: Diagnosis of Mental Disorder Complicated by Rheumatoid Arthritis: A Study of the Validity of a Psychiatrist’s Diagnosis and Questionnaire MethodLocation: Poster Hall
Abstract Poster Presenter: – Division of Rheumatology, Department of Medicine, School of Medicine, Showa University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2102: Is This Prosthetic Joint Infected or Flaring?Location: Poster Hall
Abstract Poster Presenter: – Hospital for Special Surgery
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2103: Inflammation and Immunomodulatory Therapies Influence the Relationship Between ATP-binding Cassette Transporter A1 (ABCA1)-mediated Cholesterol Efflux and Coronary Atherosclerosis in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2104: Relationship Between Frailty and Large Joint Symptoms in Rheumatoid Arthritis PatientsLocation: Poster Hall
Abstract Poster Presenter: – Japanese Red Cross Nagoya Daiichi Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2105: Cohort-wide Immuno-phenotype Deconvolute Immunological and Clinical Heterogeneity Across Autoimmune Rheumatic DiseasesLocation: Poster Hall
Abstract Poster Presenter: – The University of Tokyo / Osaka University / RIKEN
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2106: Evaluation of the Construct of Constitutional Stiffness (CS) in Anti-CCP-Antibody-Positive Rheumatoid Arthritis (ACPA+RA) and ControlsLocation: Poster Hall
Abstract Poster Presenter: – John Hunter Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2107: Social Determinants of Health and Clinical Outcomes in Rheumatoid Arthritis: A Single Center StudyLocation: Poster Hall
Abstract Poster Presenter: – Allegheny Health Network
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2108: Specific Symptom Clusters at Diagnosis Signal a Poorer Early RA Prognosis: Data from the Canadian Early Arthritis Cohort (CATCH)Location: Poster Hall
Abstract Poster Presenter: – McGill University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2109: Real-world Positivity of 14-3-3η Protein in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Rochester Regional Health- Unity Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2110: Rheumatoid Arthritis and Changes in Pulmonary Function Measures on Spirometry in a Prospective Longitudinal Cohort of SmokersLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2111: Self-reported Methotrexate Adherence Underestimates Biochemical Adherence: Results from the Methotrexate Use Improvement in Rheumatoid Arthritis Using Biomarker Feedback TrialLocation: Poster Hall
Abstract Poster Presenter: – The University of Manchester
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2112: Physical Activity in a Cohort of Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Hospital General de Agudos Dr. Enrique Tornú
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2113: Impact of Sociodemographic Factors on Efficacy and Safety of Tofacitinib in Patients with Rheumatoid Arthritis: A Post Hoc Analysis of Phase 2/3/3b/4 StudiesLocation: Poster Hall
Abstract Poster Presenter: – Grace C Wright MD PC
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2114: The Relationship Between Disease Activity of Rheumatoid Arthritis and Kidney FunctionLocation: Poster Hall
Abstract Poster Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2115: Genetic Risk Load as a Predictor of Radiographic Damage and Mortality in Female Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Hanyang University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2116: Risk of Tuberculosis in Patients with Rheumatoid Arthritis: A Nationwide Population-based Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Samsung Medical Center, Sungkyunkwan University School of Medicine
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2117: Frailty Is Associated with Mortality in Veterans with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Washington
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2118: New Onset Disability in Rheumatoid Arthritis Is an Underrecognized Cardiovascular Risk Factor: A Retrospective Cohort Study Using the CorEvitas RegistryLocation: Poster Hall
Abstract Poster Presenter: – Hospital for Special Surgery
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2119: Serum Alarmin Concentrations and Risk of Incident Major Adverse Cardiovascular Events and Heart Failure in a Multicenter, Prospective Rheumatoid Arthritis CohortLocation: Poster Hall
Abstract Poster Presenter: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2120: Independent and Combined Impact of Interstitial Lung Disease and Airway Disease on Rheumatoid Arthritis Disease Activity and InfectionsLocation: Poster Hall
Abstract Poster Presenter: – Kanazawa University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2121: Clinical Significance of Negative Seroconversion of Anti-CCP and Anti-Mutated Citrullinated Vimentin Antibodies in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Wakayama Medical University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2122: Coronary Calcium and Carotid Artery Stiffness as Predictors of Cardiovascular Events and Mortality in Patients with Rheumatoid Arthritis: A 10-year Prospective Follow-up StudyLocation: Poster Hall
Abstract Poster Presenter: – HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2123: Dose Trabecular Bone Score (TBS) Add Predictive Value to Fracture Risk Assessment (FRAX) in Rheumatoid Arthritis?Location: Poster Hall
Abstract Poster Presenter: – Chang Gung Memorial Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2124: Expansion of Atypical B Cells Accompanies Rheumatoid Arthritis-like Immune Dysregulation in ACPA+ At-risk IndividualsLocation: Poster Hall
Abstract Poster Presenter: – Allen Institute for Immunology
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2125: Comparing the ITIS Diet and the Mediterranean Diet in Rheumatoid Arthritis: Preliminary Findings on Clinical and Microbiome OutcomesLocation: Poster Hall
Abstract Poster Presenter: – UCSD
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2126: Performance of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Relation to Flares in Disease ActivityLocation: Poster Hall
Abstract Poster Presenter: – Diakonhjemmet Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2127: Associations Between Rheumatoid Arthritis, Frailty Status and Mortality in Older Adults with Bladder CancerLocation: Poster Hall
Abstract Poster Presenter: – University of Washington
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2128: Higher Vitamin D Levels Before Methotrexate Start Are Associated with Lower Subsequent Mortality in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Case Western Reserve University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2129: SCORE and SCORE2 Comparison in Cardiovascular Risk Estimation in Rheumatoid Arthritis Patients: A Cross-sectional Study Including Carotid UltrasoundLocation: Poster Hall
Abstract Poster Presenter: – Hospital General Universitario
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2130: Prevalence and Risk Factors of Pneumocystis Jirovecii Colonization in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors and TocilizumabLocation: Poster Hall
Abstract Poster Presenter: – National Taiwan University Hospital Cancer Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2131: Time-course Analysis from the First Wave to Early 2023 in Critically Ill Patients with Novel Coronavirus Infection in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Shin-Yokohama Arthritis and Rheumatology Clinic
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2132: Systematic Screening for Multimorbidities Leads to an Increased Use of Comorbidity-preventing Medications and Lower Hospitalization RatesLocation: Poster Hall
Abstract Poster Presenter: – University hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2133: Cardiovascular Risk Factors Are Associated with Discontinuation of Advanced Therapies Due to Treatment Failure in Rheumatoid Arthritis: Results from the OBRILocation: Poster Hall
Abstract Poster Presenter: – University of Toronto - Toronto
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2134: Autoantibodies to Joint-related Proteins Predict Remission with High Specificity in New Onset RALocation: Poster Hall
Abstract Poster Presenter: – Institutionen för medicin, avd för reumatologi och inflammationsforskning
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2135: Synovial Fluid High-density Lipoprotein (HDL)-miR-1246 Is Enriched in Patients with Inflammatory Arthritis Compared to Osteoarthritis and Increases Synovial Fibroblast IL-6 ExpressionLocation: Poster Hall
Abstract Poster Presenter: – Vanderbilt University Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2136: Arthritogenic Cells Found in the Peripheral Blood of Rheumatoid Arthritis Patients Transfer the Disease to NSG-DR4 MiceLocation: Poster Hall
Abstract Poster Presenter: – Medical University of Graz
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2137: Line of Therapy of Biologics and JAK Inhibitors in RA, PsA and AxSpA: Implications for Design and Uptake of New Drugs and DiagnosticsLocation: Poster Hall
Abstract Poster Presenter: – Illumination Health
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2138: Frailty Is a Predictor of Incident Osteoporotic Fractures in Veterans with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – VA PUGET SOUND/UNIVERSITY OF WASHINGTON
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2139: Associations of Adipocytokines with Cancer Incidence in a Prospective Rheumatoid Arthritis CohortLocation: Poster Hall
Abstract Poster Presenter: – University of Washington
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2140: Serum Alarmins and the Risk of Interstitial Lung Disease in Patients with Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2141: Glucocorticoid Treatment in Early Rheumatoid Arthritis Is Associated with Increased Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Levels: A Post-hoc Analysis of a Randomized Controlled Trial (NORD-STAR)Location: Poster Hall
Abstract Poster Presenter: – Amsterdam UMC, Karolinska Institute
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2142: Adherence Patterns in Rheumatoid Arthritis Patients Receiving a Janus Kinase (JAK) Inhibitor or a Tumor Necrosis Factor α Inhibitor (TNFi) After the Addition of a Black Box Warning to JAK InhibitorsLocation: Poster Hall
Abstract Poster Presenter: – university of florida
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2143: Efficacy of Filgotinib in Patients with Rheumatoid Arthritis: Week 156 Results from a Long-term Extension StudyLocation: Poster Hall
Abstract Poster Presenter: – UNIVERSITY OF MANCHESTER
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2144: Pharmacodynamic Effects of Nipocalimab in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA): Results from the Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2A IRIS-RA StudyLocation: Poster Hall
Abstract Poster Presenter: – Janssen Pharmaceuticals Inc.
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2145: Patterns of Use, Effectiveness, Persistence and Cardiovascular Risk in Patients with Rheumatic Diseases Treated with Upadacitinib in a Real-world Setting. UPAREAL StudyLocation: Poster Hall
Abstract Poster Presenter: – Rheumatologist
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2146: After JAK Inhibitor Failure, "Switching" or "Cycling"?Location: Poster Hall
Abstract Poster Presenter: – Hospital Universitario y Politécnico La Fe
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2147: Safety and Effectiveness in Cycling Between Non-Selective and Selective JAKi in a Multi-Center Registry of Rheumatoid Arthritis in the Middle EastLocation: Poster Hall
Abstract Poster Presenter: – Cleveland Clinic Abu Dhabi
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2148: Do High RF Titers Impact Response to TNF Inhibitors? Comparison of Certolizumab Pegol and Adalimumab in Patients with RA and High Titers of RF: A Post Hoc Analysis of a Phase 4 TrialLocation: Poster Hall
Abstract Poster Presenter: – Medical University of Vienna
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2149: Biologic IRL201805 Drives Differential Cell-contact and Metabolism Transcriptional Profiles in Monocytes from RA Patients Compared to Healthy DonorsLocation: Poster Hall
Abstract Poster Presenter: – School of Infection & Immunity, University of Glasgow
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2150: Novel Biologic IRL201805 Inhibits Osteoclastogenesis in Monocytic Cells from RA PatientsLocation: Poster Hall
Abstract Poster Presenter: – School of Infection & Immunity, University of Glasgow
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2151: Effects of Methotrexate on Blood Pressure in Rheumatoid Arthritis: A Randomized Controlled TrialLocation: Poster Hall
Abstract Poster Presenter: – SA Health
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2152: Survival Benefits of Knee and Hip Arthroplasty in Patients with Rheumatoid Arthritis: A General Population-based Cohort StudyLocation: Poster Hall
Abstract Poster Presenter: – Department of Orthopaedics, Xiangya Hospital, Central South University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2153: Effects of One-year Tofacitinib Therapy on Angiogenic Biomarkers in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – University of Debrecen
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2154: Two-Year Persistence of First-Line Biological or JAK Inhibitor Treatment in Patients with Long-Standing Rheumatoid Arthritis and Failure of Triple Therapy with Synthetic DMARDsLocation: Poster Hall
Abstract Poster Presenter: – Clínica Alemana de Santiago
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2155: The Impact of Filgotinib on Disease Activity Outcomes with Concomitant Pain Control in the Phase 3 FINCH StudiesLocation: Poster Hall
Abstract Poster Presenter: – University of Oxford
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2156: Efficacy of Olokizumab in Comorbid Depressive Disorder in Patients with Rheumatoid Arthritis: Preliminary Results of a StudyLocation: Poster Hall
Abstract Poster Presenter: – Stanford University School of Medicine, Palo Alto CA
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2157: Exploratory Analysis of the Mechanisms of Action of the Potential Analgesic Effect of Tofacitinib and Adalimumab over Placebo in Patients with Rheumatoid Arthritis: Results of a Mediation Modeling AnalysisLocation: Poster Hall
Abstract Poster Presenter: – Université de Paris France
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2158: Continued Nintedanib Treatment in Patients with Progressive Pulmonary Fibrosis Related to Autoimmune Disease: Data from INBUILD-ONLocation: Poster Hall
Abstract Poster Presenter: – Mayo Clinic College of Medicine and Science
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2159: Results of a 24-week Open-label, Non-interventional Study of the Efficacy and Safety of Olokizumab Therapy in Patients with Rheumatoid Arthritis After Switching from Anti-B-cell Therapy During the SARS-COV-2 PandemicLocation: Poster Hall
Abstract Poster Presenter: – R-Pharm
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2160: Poly-Refractory Rheumatoid Arthritis: All B/tsDMARD Classes Exhausted - An Uncommon Disease Subset with Distinct Inflammatory and Non-inflammatory PhenotypesLocation: Poster Hall
Abstract Poster Presenter: – Medical doctor graduated in Rio de Janeiro State University, Internal Medicine resident in Sheba Medical Center Tel Hashomer, Experimental Rheumatology Fellow in University of Leeds, UK
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2161: Pharmacokinetic and Safety Similarity of High- and Low-Concentration Formulations of Adalimumab Biosimilar ABP 501Location: Poster Hall
Abstract Poster Presenter: – Amgen
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2162: Safety and Efficacy of Filgotinib: An Update from the DARWIN 3 Phase 2 Long-term Extension with a Maximum of 8.2 Years of ExposureLocation: Poster Hall
Abstract Poster Presenter: – University of Leeds
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2163: Omnipresent Poor Prognostic Factors in Early Rheumatoid Arthritis in the IMPROVED Trial; Is Earlier bDMARD Treatment Escalation for All Necessary?Location: Poster Hall
Abstract Poster Presenter: – Leiden University Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2164: Real-world Persistence of Initial Targeted Therapy Strategy in Monotherapy versus Combination Therapy in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisLocation: Poster Hall
Abstract Poster Presenter: – Fundacion Española de Reumatología
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2165: Efficacy of Abatacept in Rheumatoid Arthritis- associated Usual Interstitial Pneumonia. National Multicenter Study of 233 Patients During a Long-Term Follow UpLocation: Poster Hall
Abstract Poster Presenter: – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2166: Long-Term Effects of Abatacept on Arthritis and Atherosclerosis in Older vs Younger Patients with Rheumatoid Arthritis: 3-year Results of a Prospective, Multicenter, Observational StudyLocation: Poster Hall
Abstract Poster Presenter: – Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2167: 24-week, Post-Marketing Surveillance Analysis of Upadacitinib in Japanese Patients with Rheumatoid Arthritis (Encore1)Location: Poster Hall
Abstract Poster Presenter: – Yamagata University Faculty of Medicine
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2168: The Potential of Autologous Patient-derived Circulating Extracellular Vesicles to Improve Drug Delivery in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – CAHIM SHEBA MEDICAL CENTER
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2169: Cost-utility of a Progressive Spacing of Tocilizumab or Abatacept in Patients with Rheumatoid Arthritis in Sustained Remission: A Medico-economic Analysis of the Towards the Lowest Efficacious Dose TrialLocation: Poster Hall
Abstract Poster Presenter: – Sorbonne University - APHP
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2170: Systemic Glucocorticoids Are Associated with a Time and Dose-dependent Risk of Major Adverse Cardiovascular Event in Patients with Rheumatoid Arthritis: A Population-based StudyLocation: Poster Hall
Abstract Poster Presenter: – The Chinese University of Hong Kong
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2171: Common IL-6 Signaling Is Inhibited by IL-6 Inhibitors and JAK Inhibitors, but Which Is Better at Preventing Bone Destruction in RA?Location: Poster Hall
Abstract Poster Presenter: – Japanese Red Cross Okayama Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2172: Subcutaneus vs Intravenous Abatacept in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 509 PatientsLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario Marqués de Valdecilla, IDIVAL
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2173: Window of Opportunity in the Treatment of Rheumatoid Arthritis-Interstitial Lung Disease with Abatacept. National Multicenter Study of 509 PatientsLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario Marqués de Valdecilla, IDIVAL
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2174: JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 73 Patients, 55 of BaricitinibLocation: Poster Hall
Abstract Poster Presenter: – Hospital Universitario Marqués de Valdecilla, IDIVAL
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2175: Real-World Drug Persistence of GP2015, an Etanercept Biosimilar, in Patients with Rheumatoid Arthritis: Results from the Multi-Country COMPACT StudyLocation: Poster Hall
Abstract Poster Presenter: – University Hospital Wuerzburg
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
9:00 AM – 11:00 AM PT2176: Cellular and Proteomic Changes Following Administration of Peresolimab, in a Phase 2a Trial in Rheumatoid ArthritisLocation: Poster Hall
Abstract Poster Presenter: – Eli Lilly and Company
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
11:15 AM – 11:25 AM PT2426: The Role of β-catenin in Synovial Lining Fibroblast DifferentiationLocation: Exhibit Hall A-B
Plenary Presenter: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:00 PM – 3:00 PM PT14T144: Reconstructing Rheumatoid Arthritis Through Space and Time. New Insights into RA Pathology from the AMP RA/SLE ConsortiumLocation: Room 23A-C
Moderator: – Hospital for Special Surgery
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:00 PM – 2:15 PM PTInsights from B and T Cell Repertoire Studies in Rheumatoid Arthritis Blood and SynoviumLocation: Room 23A-C
Speaker: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:15 PM – 2:30 PM PTEpigenetics of Synovitis: Atacseq and Next Generation Omics Studies in RALocation: Room 23A-C
Speaker: – Harvard University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:30 PM – 2:45 PM PTCellular Architecture of Synovitis: Imaging of Rheumatoid Arthritis SynoviumLocation: Room 23A-C
Speaker: – The University of Birmingham
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:45 PM – 3:00 PM PTQ&ALocation: Room 23A-C
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:00 PM – 3:30 PM PT14T155: Abstracts: RA – Diagnosis, Manifestations, & Outcomes III: Predicting & Optimizing Outcomes (2479–2484)Location: Ballroom 20B-C
Abstract Moderator: – University of Alabama at Birmingham (UAB), Birmingham VA Medical Center
Abstract Moderator: – Mayo Clinic
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:00 PM – 3:30 PM PT14T156: Abstracts: RA – Etiology & Pathogenesis (2431–2436)Location: Room 29A-D
Abstract Moderator: – Stanford University
Abstract Moderator: – Friedrich-Alexander-Universität Erlangen-Nürnberg
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:00 PM – 2:10 PM PT2431: Integrated Single Cell Multi-omics Analysis in At-Risk for Future Rheumatoid Arthritis (RA) and Early RA Reveals Shared Transcription Factor Profiles in Multiple Cell LineagesLocation: Room 29A-D
Presenting Author: – University of California San Diego
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:00 PM – 2:10 PM PT2479: Tolerability and Effectiveness of Antifibrotics in Rheumatoid Arthritis-associated Interstitial Lung DiseaseLocation: Ballroom 20B-C
Presenting Author: – Division of Rheumatology, Inflammation, and Immunity Brigham & Women’s Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:15 PM – 2:25 PM PT2432: Wnt Signaling Drives Pathogenic Stromal Inflammation in Inflammatory ArthritisLocation: Room 29A-D
Presenting Author: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:15 PM – 2:25 PM PT2480: Definition of Rheumatoid Arthritis Flare Based on SDAI and CDAILocation: Ballroom 20B-C
Presenting Author: – Medical University of Vienna
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:30 PM – 2:40 PM PT2433: Longitudinal Multi-Omics Single Cell Analysis Reveals Abatacept Treatment Shifts Peripheral Lymphocyte Subpopulations in Seropositive RA with Reduction of Mature B Cells and Retention of Transitional and Naive B CellsLocation: Room 29A-D
Presenting Author: – New York School of Medicine
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:30 PM – 2:40 PM PT2481: Pre-pregnancy Gene Expression Signatures Among Women with Rheumatoid Arthritis May Represent Predictive Biomarkers for Subsequent Improvement or Worsening During PregnancyLocation: Ballroom 20B-C
Presenting Author: – Northwestern University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:45 PM – 2:55 PM PT2434: Acetylated Bacterial Proteins as Potent Antigens Inducing an Anti-modified Protein Antibody ResponseLocation: Room 29A-D
Presenting Author: – Leiden University Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
2:45 PM – 2:55 PM PT2482: Preinflammatory Mesenchymal (PRIME) Cell Signature Genes Enrichment Predicts Treatment Response and Joint Prognosis in Rheumatoid ArthritisLocation: Ballroom 20B-C
Presenting Author: – Kyoto University
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
3:00 PM – 3:10 PM PT2435: Deciphering Rheumatoid Arthritis Disease Activity-Associated Gene Signatures and Cell Subsets Through Single Cell TranscriptomicsLocation: Room 29A-D
Presenting Author: – Sorbonne University - UCSF
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
3:00 PM – 3:10 PM PT2483: CD68 and Fibrinoid Necrosis Are Synovial Biomarkers of Severity in Early Rheumatoid Arthritis and Are Associated with a Better Response to Methotrexate: Analysis of the UCLouvain Brussels ERA CohortLocation: Ballroom 20B-C
Presenting Author: – UCLouvain University / Sapienza University of Rome
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
3:15 PM – 3:25 PM PT2436: Characterizing Spatial Organization of Immune Infiltrates in Rheumatoid Arthritis Synovia Using Spatial Transcriptomic AnalysisLocation: Room 29A-D
Presenting Author: – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
3:15 PM – 3:25 PM PT2484: Optimizing the Care of the Rheumatic Patient with Rheumatologist-Pharmacist Co-managementLocation: Ballroom 20B-C
Presenting Author: – Geisinger Medical Center
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
4:00 PM – 5:30 PM PT14T176: Abstracts: RA – Treatments III: Predictors of Response & Tapering (2539–2544)Location: Ballroom 20B-C
Abstract Moderator: – Feinstein Institutes for Medical Research
Abstract Moderator: – Northwell Health
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
4:00 PM – 4:10 PM PT2539: Baseline IL-10 Levels as a Predictive Biomarker for Achieving Clinical Response with Abatacept in ACPA+ Patients with Early RALocation: Ballroom 20B-C
Presenting Author: – Bristol Myers Squibb
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
4:15 PM – 4:25 PM PT2540: The Molecular Stratification of Rheumatoid Arthritis Using High-throughput Technologies Is Directly Associated with Disease Activity and Clinical ResponseLocation: Ballroom 20B-C
Presenting Author: – IMIBIC/Reina Sofia Hospital/University of Cordoba
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
4:30 PM – 4:40 PM PT2541: Differential Responses to Initial Treatment Strategies for Rheumatoid Arthritis Among Those with Lower Body Mass and AdiposityLocation: Ballroom 20B-C
Presenting Author: – University of Pennsylvania
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
4:45 PM – 4:55 PM PT2542: Impact of Concomitant Methotrexate on Disease Activity After Tapering Abatacept in Patients with Rheumatoid Arthritis: A Nationwide Cohort StudyLocation: Ballroom 20B-C
Presenting Author: – Seoul National University Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
5:00 PM – 5:10 PM PT2543: Clinical and Radiographic Results of Tapering and Withdrawing CsDMARDs versus Stable Treatment in Patients with Rheumatoid Arthritis in Remission: 3-year Results from a Randomized Controlled TrialLocation: Ballroom 20B-C
Presenting Author: – Diakonhjemmet Hospital
Rheumatoid arthritis (RA)
-
Tuesday, Nov 14th
5:15 PM – 5:25 PM PT2544: Microbial Metabolism of Methotrexate Contributes to Its Pharmacokinetics in VivoLocation: Ballroom 20B-C
Presenting Author: – University of California, Santa Barbara
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
8:45 AM – 9:00 AM PTL20: Telitacicept, a Human Recombinant Fusion Protein Targeting and Neutralizing B Lymphocyte Stimulator (BlyS) and a Proliferation-Inducing Ligand (APRIL), in Rheumatoid Arthritis (RA) Patients with an Inadequate Response to Methotrexate (MTX): A Randomized, Double-Blind, Phase 3 StudyLocation: Room 6A-B
Presenting Author: – RemeGen Biosciences
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
8:00 AM – 9:00 AM PT15W109: RA Treatment: Are We Good Enough?Location: Room 24A-C
Moderator: – Columbia University Medical Center
Moderator: – Harvard Medical School
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
8:00 AM – 8:25 AM PTHow Has RA Evolved?Location: Room 24A-C
Speaker: – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
8:25 AM – 8:50 AM PTIn Whom Should We Taper csDMARDs, or Advanced Therapies in Rheumatoid Arthritis? Should We Attain Drug-Free Remission?Location: Room 24A-C
Speaker: – University of Leeds
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
8:50 AM – 9:00 AM PTQ&ALocation: Room 24A-C
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
9:15 AM – 10:15 AM PT15W127: The Evolution of Clinical Research in Vasculitis: Lessons Learned for the Study of Rare DiseasesLocation: Room 6F/6C
Moderator: – West Virginia University
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
9:15 AM – 10:00 AM PTThe Evolution of Clinical Research in Vasculitis: Lessons Learned for the Study of Rare DiseasesLocation: Room 6F/6C
Speaker: – University of Pennsylvania
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
10:00 AM – 10:15 AM PTQ&ALocation: Room 6F/6C
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
11:00 AM – 12:30 PM PT15W123: Abstracts: RA – Diagnosis, Manifestations, and Outcomes IV: Pre-RA & RA Diagnosis (2581–2586)Location: Room 23A-C
Abstract Moderator: – University of Colorado Denver Anschutz Medical Campus
Abstract Moderator: – University of California San Diego
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
11:00 AM – 11:10 AM PT2581: Proteomic Signatures in Pre-Rheumatoid Arthritis Suggest Evolving Biological Pathways in Different Stages of Disease Development That May Inform Prediction and Prevention StrategiesLocation: Room 23A-C
Presenting Author: – Allen Institute for Immunology
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
11:15 AM – 11:25 AM PT2582: Expansion of Circulating HLA-DR+ Peripheral Helper T Cells and CXCR5−CD38+ Mature Naïve B Cells in ACPA-positive Individuals At-risk for and with Classified RALocation: Room 23A-C
Presenting Author: – University of Colorado Anschutz Medical Campus
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
11:30 AM – 11:40 AM PT2583: A Predictive Model for Progression to Clinical Arthritis Based on Lymphocyte Subsets and ACPA in At-risk Individuals with ArthralgiaLocation: Room 23A-C
Presenting Author: – Institute of Rheumatology
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
11:45 AM – 11:55 AM PT2584: Gut Microbiome and Intestinal Inflammation in Preclinical Stages of Rheumatoid ArthritisLocation: Room 23A-C
Presenting Author: – Unige
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
12:00 PM – 12:10 PM PT2585: Cytokine and Chemokine Elevations in ACPA+ Individuals Suggest Possible Viral, Mucosal and/or Innate Responses Are Related to the Transition to Future Clinical RALocation: Room 23A-C
Presenting Author: – University of Colorado
Rheumatoid arthritis (RA)
-
Wednesday, Nov 15th
12:15 PM – 12:25 PM PT2586: A Novel Blood-Based Assay Differentiates Seropositive and Seronegative Rheumatoid Arthritis from Healthy Individuals and Those with Other Inflammatory Diseases or OsteoarthritisLocation: Room 23A-C
Presenting Author: – University of Oxford
Rheumatoid arthritis (RA)
